Brief: Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
04/02/2025 13:52
Feb 4 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES AND RESTORATION BIOLOGICS ANNOUNCE
LICENSING
AGREEMENTS TO TREAT JOINT DISEASE
* ENVERIC BIOSCIENCES INC - MILESTONE PAYMENTS COULD TOTAL
$61
MILLION FOR PHARMACEUTICAL LICENSE
* ENVERIC BIOSCIENCES INC - MILESTONE PAYMENTS COULD TOTAL
$21
MILLION FOR NON-PHARMACEUTICAL LICENSE
Source text: ID:nBw2K4BM5a
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003